Proactive Investors - Run By Investors For Investors

Cannabis group iAnthus unveils $835m takeover of MPX Bioceutical

The combined company will boast cannabis licenses in 10 US states
cannabis and wad of bills
MPX shareholders will be awarded 0.1673 shares of iAnthus for each share of MPX held

The cannabis group iAnthus Capital Holdings Inc (CSE:IAN, OTCQB:ITHUF) is widening its reach across the US by acquiring its Toronto-based rival MPX Bioceutical (CSE:MPX, OTC:MPXEF) in an all-stock deal worth C$835 million (US$636m).

The combined company will boast cannabis licenses in 10 US states that will offer iAnthus the chance to operate 56 retail locations and 14 cultivation and processing facilities.

After the deal is done, iAnthus will add production capabilities in Arizona, Maryland, Nevada, California and Massachusetts. These additional licenses complement iAnthus’s existing foothold in New York, Florida, Vermont, Colorado and New Mexico.

The deal follows last week’s announcement that MedMen Enterprises has moved to take over the medical marijuana company PharmaCann in an all-stock deal valued at $682 million.

READ: iAnthus Capital Holdings' revenue climbs in first half of 2018, but sees a net loss of US$36.2mln

“This is a watershed moment for iAnthus, as we nearly double the size of our national footprint in the US, said iAnthus CEO Hadley Ford in a statement.

The 10 states combined are set to provide as much as $16.2 billion in yearly cannabis sales by 2022, according to statistics from Arcview Market Research and BDS Analytics.

Under the agreement’s terms, MPX shareholders will be awarded 0.1673 shares of iAnthus for each share of MPX held, which represents a consideration of about $1.28 per MPX share.

iAnthus shares fell 6.7% to C$7.64 while MPX shares slipped 4.2% to C$1.14 in Friday’s afternoon trading session.

 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full IAN profile View Profile

iAnthus Capital Holdings Inc. Timeline

Related Articles

cannabis extract
January 16 2019
The Kelowna, BC-based cannabis company specializes in the research, development, production, and testing of high-quality cannabis extracts and oils
muffins and cannabis
November 29 2018
Dehydratech is essentially a delivery system that allows drugs and vitamins to get into the bloodstream quicker, while making them taste and smell better at the same time
cannabis tablet
February 28 2019
The company fills a niche in the medicinal cannabis market, as it continues to push forward its suite of precision oral dose products
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use